Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -73.14% | -72.60% | -2.47% | -6.20% | -63.15% |
| Total Depreciation and Amortization | -52.80% | -52.85% | 3.36% | 6.93% | 46.56% |
| Total Amortization of Deferred Charges | 2,694.74% | 2,742.11% | 324.00% | 340.50% | -83.76% |
| Total Other Non-Cash Items | 421.00% | 419.40% | 3,246.15% | 3,541.67% | 41.99% |
| Change in Net Operating Assets | 140.57% | 140.46% | -147.49% | -149.23% | -233.53% |
| Cash from Operations | 94.66% | 94.69% | -43.74% | -48.92% | -2,147.41% |
| Capital Expenditure | -205.26% | -210.53% | -- | -- | 86.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 89.30% | 89.25% | 100.88% | 100.91% | 64.29% |
| Cash from Investing | 82.26% | 82.35% | 100.86% | 100.88% | 65.64% |
| Total Debt Issued | -- | -- | -71.20% | -71.20% | -100.00% |
| Total Debt Repaid | 70.41% | 70.41% | 51.67% | 51.67% | 81.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.49% | -99.49% | -77.21% | -76.34% | 700.08% |
| Foreign Exchange rate Adjustments | -224.19% | -222.83% | 256.82% | 262.79% | 788.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.49% | -114.45% | -4.96% | -8.73% | 551.82% |